Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  etanercept
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-15 of 15 for your search:
Start Over
Can We Miss Pigmented Lesions in Psoriasis Patients?
Phase: Phase IV
Type: Diagnostic
Status: Completed
Age: 19 and over
Sponsor: Other
Protocol IDs: F070629011, NCT01053819
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000257027, NCCTG-N00C1, NCI-P02-0232, MC00C8, 1497-00, N00C1, NCT00046904
Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, NHLBI
Protocol IDs: 465, BMT CTN 0403, 5U 01H1069294, NCT00421174
The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease
Phase: Phase III
Type: Supportive care
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: UMCC 2007.139, HUM 17897, NCT00726375
Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-0113, NCT00201682
Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-0041, NCT00201838
Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 1888.00, FHCRC-1888.00, CDR0000380742, NCT00093366
Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 1926.00, NCI-2011-01818, FHCRC-1926.00, 5967, PHARMION-FHCRC-1926.00, NCT00118287
Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 16 and over
Sponsor: NINR
Protocol IDs: 020133, 02-NR-0133, NCT00031551
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: ASCT0521, NCI-2009-00429, COG-PBMTC-SUP051, COG-ASCT0521, CDR0000456407, U10CA098543, NCT00309907
Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 10 and over
Sponsor: NCI, NHLBI
Protocol IDs: BMTCTN0302, U01HL069294-05, 285, JHOC-05040403, JHOC-J0519, NCT00224874
Biological Therapy in Treating Patients With Myelodysplastic Syndrome
Phase: Phase II
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1478.00, FHCRC-1478.00, NCI-G00-1793, CDR0000067878, NCT00005853
Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 1872.00, FHCRC-1872.00, CDR0000430702, 5740, NCT00217386
Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: umcc 2008.003, NCT00639717
Phase I Multipart Study of High-Dose IL-2 in Combination with the TNF Receptor IgG Chimera TNFR:Fc in Patients with Advanced Malignancies (Summary Last Modified 01/94)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: NEMCH-B93-0007, NCI-B93-0007, B93-0007
Start Over